2024-11-20 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products.

The cumulative return of LLY is 570.83%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 125.6%.  The difference in cumulative returns is 445.23%, placing it at the 66.52nd percentile of its historical performance relative to the S&P 500 (based on the provided maximum and minimum divergence).  This indicates strong outperformance.  The provided Alpha and Beta analysis further reinforces this, consistently showing positive alpha (outperformance relative to the market) and a beta generally around 0.7 (meaning it's somewhat less volatile than the overall market).

**2. Recent Price Movement:**

* **Closing Price:** $729.73 (Last market: $729.87)
* **5-day Moving Average:** $759.71
* **20-day Moving Average:** $821.42
* **60-day Moving Average:** $883.72

The stock price is currently trading below all three moving averages, suggesting a downward trend.

**3. Technical Indicators and Expected Return:**

* **RSI (25.14):**  Indicates the stock is in oversold territory, potentially suggesting a bounce is possible.
* **PPO (-1.12):**  Negative value suggests bearish momentum.
* **20-day Relative Divergence (-24.17):** Shows a recent sharp decline in relative performance against the S&P 500.
* **Expected Return (169.22%):** This represents a significant outperformance relative to the S&P 500 over the long term (2+ years) if a long-term investment strategy is adopted.  However, this needs to be considered with caution as this prediction is based on past performance which is not a guarantee of future results.  The current price ($729.87) is not explicitly stated as being significantly higher or lower than a key level; this lack of context means no specific 'sudden jump/drop' comments can be made here.

**4. Recent Financial Performance and Outlook:**

The provided EPS and Revenue figures show volatility. While there were strong performances in Q2 and Q3 2024, Q4 2023 showed a loss.  More information, including analyst estimates for Q4 2024 earnings and overall future prospects, is needed for a complete assessment.  The erratic earnings reported should be noted.


**6. Financial Information Analysis:**

* **Revenue and Profitability:**  Revenue is relatively stable, showing minor fluctuations.  Profit margins are consistently high (around 80%), indicating strong profitability.
* **Capital and Profitability:** ROE (Return on Equity) is variable, with significant fluctuations quarter to quarter. This necessitates further investigation to determine the underlying causes.

**7. News and Recent Issues:**

* _**Requires information:**_  To fulfill this section, please provide news articles from sources like Shacknews or FINBOLD (or similar reputable sources) published within the last two days concerning LLY.  This will allow for a comprehensive analysis of recent market outlook, analyst opinions, and performance highlights.

**8. Summary:**

LLY has significantly outperformed the S&P 500 over the long term, demonstrating strong historical returns.  However, the recent price action reveals a downtrend, supported by technical indicators suggesting an oversold condition but also bearish momentum.  The financial performance shows variability, with high profit margins yet uneven earnings.  More data is needed regarding the recent earnings announcement and analyst forecasts for a complete picture. The high expected return is promising, but investors should be cautious considering the recent price dip and volatility in both earnings and ROE.  The absence of recent news necessitates supplementary information for a truly comprehensive conclusion.


**9. Disclaimer:** This analysis is based on the provided data and publicly available information. It is not financial advice and should not be the sole basis for investment decisions.  Consult with a qualified financial advisor before making any investment choices.
